NCT04877444

Brief Summary

Stroke is a leading cause of disability in the U.S. and many Veteran stroke survivors live with severe disability. Despite recent advances in rehabilitation treatments many stroke survivors have persistent physical and mental difficulties such as reduced physical and cognitive function and depression. Developing innovative treatments that address these problems is necessary to improve long-term outcomes for stroke survivors. Aerobic exercise (AEx) can improve physical and cognitive function, and reduce depression. Additionally, AEx may enhance physical rehabilitation by making the brain more receptive to, and consequently improving the response to an intervention. Therefore, combining AEx with physical rehabilitation has the potential to improve multiple aspects of stroke recovery. This study will examine the effect of combining AEx with physical rehabilitation on physical and mental function in stroke survivors. By gaining a better understanding of the effects of this combined intervention the investigators aim to advance the rehabilitative care of Veteran stroke survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for early_phase_1 stroke

Timeline
9mo left

Started Jul 2021

Longer than P75 for early_phase_1 stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Jul 2021Jan 2027

First Submitted

Initial submission to the registry

April 26, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

5.3 years

First QC Date

April 26, 2021

Last Update Submit

January 7, 2026

Conditions

Keywords

rehabilitationexercisebrain-derived neurotrophic factorupper extremity

Outcome Measures

Primary Outcomes (1)

  • Change from baseline upper extremity impairment assessed by the Fugl Meyer Upper Extremity Assessment (FMA-UE)

    The FMA-UE is a 33-item measure of UE impairment; however, the 3 items testing reflex response will not be administered because they do not measure a voluntary movement construct. Each item will be scored on a 3-point rating scale (0=unable, 1=partial 2=near normal performance), item ratings will be summed and reported out of 60 points so that larger numbers indicate greater UE motor ability.

    Approximately 8 weeks

Secondary Outcomes (7)

  • Change from baseline upper extremity motor function assessed by the Wolf Motor Function Test (WMFT)

    Approximately 8 weeks

  • Change from baseline locomotor function assessed by self-selected walking (SSWS) speed and six-minute walk test (6MWT)

    Approximately 8 weeks

  • Change from baseline health related quality of life assessed by the Stroke Impact Scale (SIS)

    Approximately 8 weeks

  • Change from baseline depressive symptoms assessed by the Geriatric Depression Scale (GDS)

    Approximately 8 weeks

  • Change from baseline cognitive function assessed by National Institutes of Health Toolbox - Cognition Battery (NIHTB-CB)

    Approximately 8 weeks

  • +2 more secondary outcomes

Study Arms (2)

Aerobic exercise (AEx) + upper extremity rehabilitation

EXPERIMENTAL

Subject will receive a total of 24 intervention sessions. In each session, subjects will perform 15 minutes of AEx followed by 200 repetitions of an upper extremity rehabilitation program.

Device: Duck Duck PunchBehavioral: Aerobic exercise

Stretching (CON) + upper extremity rehabilitation

EXPERIMENTAL

Subjects will perform 15 minutes of lower extremity stretching. Following lower extremity stretching subjects will receive 200 repetitions of DDP.

Device: Duck Duck PunchBehavioral: Lower extremity stretching

Interventions

Duck Duck Punch (DDP) is an interactive computer game deliberately designed to enhance UE movement quality via individualized progressive movement practice. DDP is unique as it uses Microsoft Kinect skeletal tracking technology to assess movement performance. The participant sits in front of the Microsoft Kinect and controls a virtual arm with his/her physical arm; reaching forward to "punch" virtual ducks. The goal 'dose' of DDP will be 200 repetitions.

Also known as: DDP
Aerobic exercise (AEx) + upper extremity rehabilitationStretching (CON) + upper extremity rehabilitation

Subjects will perform 15 minutes of aerobic exercise on a recumbent stationary cycle. The target intensity of aerobic exercise is 70% heart rate reserve. Following aerobic exercise subject will play an upper extremity rehabilitation game called Duck Duck Punch.

Also known as: AEx
Aerobic exercise (AEx) + upper extremity rehabilitation

Subjects will perform 15 minutes of lower extremity stretching. Following aerobic exercise subject will play an upper extremity rehabilitation game called Duck Duck Punch.

Also known as: CON
Stretching (CON) + upper extremity rehabilitation

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • experienced unilateral stroke at least 6 months prior;
  • voluntarily shoulder flexion of the affected arm 20 degrees with simultaneous elbow extension 10 degrees;
  • moderate arm movement impairment (UE Fugl-Meyer Assessment \> 21 but \< 52 points;
  • passive range of motion in paretic shoulder, elbow, wrist, thumb and fingers within 20 degrees of normal;
  • years of age;
  • ability to communicate as per the therapists' judgement at baseline testing;
  • ability to complete and pass an exercise tolerance test; 8) Box \& Block test score of at least 3 blocks in 60 seconds with the affected arm.

You may not qualify if:

  • lesion in brainstem/cerebellum as these may interfere with visual-perceptual/cognitive skills needed for motor re-learning;
  • presence of other neurological disease that may impair motor learning skills;
  • orthopedic condition or impaired corrected vision that alters reaching ability (e.g., prior rotator cuff tear without full recovery);
  • paretic arm pain that interferes with reaching;
  • unable to understand or follow 3-step directions;
  • severe cognitive impairment (MoCA score 17);
  • severe aphasia;
  • inability to read English,
  • history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during ADL's;
  • Severe hypertension with systolic \>200 mmHg and diastolic \>110 mmHg at rest;
  • History of COPD or oxygen dependence;
  • History of DVT or pulmonary embolism within 6 months;
  • Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions;
  • UBACC score \< 15; and for brain stimulation procedures only:
  • electronic or metallic implants;
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, 29401-5703, United States

RECRUITING

MeSH Terms

Conditions

StrokeMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ryan E Ross, PhD

    Ralph H. Johnson VA Medical Center, Charleston, SC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ryan E Ross, PhD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The primary outcome measure will be assessed by a blinded rater to improve scientific rigor.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Study participants will be randomized to one of two groups. One group will receive 24 sessions of aerobic exercise and upper extremity rehabilitation. The second group will receive 24 sessions of stretching exercise and upper extremity rehabilitation.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2021

First Posted

May 7, 2021

Study Start

July 1, 2021

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

January 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations